Recon: Merck, Moderna vaccine cut spread of skin cancer 65% in midstage trial; FDA allows imports of unapproved Chinese chemo drugs amid shortage
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy